Life Sciences Scoop | May 2023
Warman O'Brien
Global Life Sciences Recruitment Partner across the USA, UK, Europe and APAC
Greetings and welcome to our May newsletter! With the weather warming up, we're excited to share our latest news and career opportunities with you.
In this month's edition, we have a diverse range of jobs available across the US in fields such as #Bioinformatics, #Scientific, #StatisticalProgramming, #Biostatistics, #RegulatoryAffairs, and #Medical. Additionally, we're thrilled to bring you insights from influential experts in the industry.
We hope you enjoy reading our May newsletter and look forward to staying connected with you!
Join Us at Two Game-Changing Conferences in May
We're pleased to announce that our team is crossing the Atlantic this month to exhibit at two major conferences: PharmaSUG 2023 in San Francisco (BOOTH 208) and American Society of Gene & Cell Therapy ’s Annual Meeting (BOOTH 431) in Los Angeles. We're looking forward to meeting you in person, so don't forget to stop by our booths!
PharmaSUG 2023 is the foremost event for #StatisticalProgrammers and #Biostatisticians in the Life Sciences. If you're attending, we'd love to chat with you about your career aspirations or help you with your recruitment needs.
The American Society of Gene & Cell Therapy ’s Annual Meeting is a fantastic opportunity for us to learn about the latest #scientific #research and new technologies while networking with our peers.
Jobs of the month:
BIOINFORMATICS (West Coast)
STATISTICAL PROGRAMMING
SCIENTIFIC
BIOSTATISTICS
领英推荐
REGULATORY AFFAIRS
MEDICAL
What to read:
The top 10 list is based on?Evaluate Ltd's 2023 preview, where the analysts assess what they see as the biggest-selling drugs that will be approved this year in terms of sales by 2028.
AbbVie's Qulipta has been approved by the FDA to treat chronic migraine, in addition to its existing approval for episodic migraine. Qulipta is now the only oral CGRP receptor antagonist for both migraine types. It demonstrated significant reduction in monthly migraine days and improved functioning in patients with chronic migraine. AbbVie's migraine portfolio also includes Botox for chronic migraine and Ubrelvy for acute migraine, which generated over $3bn in revenue in 2022.
According to a Fierce Biotech analysis,?in the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump compared to 2022, when 30 companies reported layoffs for the same period.
Who are we?
Warman O'Brien is a global Life Sciences Recruitment partner. We're proud to say that we have a 90% success rate of CV-to-interview matches, and our partnerships with pioneering?#Biotech,?#Pharma, and?#CROs?across the USA, UK and Europe. We recruit top talent across multiple functional areas, including?#Biometrics,?#DataScience,?#QualityAssurance,?#RegulatoryAffairs,?#ClinicalResearch,?#DiscoverySciences, and?#Medical.
Follow us on LinkedIn?for daily updates and be the first to apply for the hottest jobs of the week!